TCM FC-RS
TCM Clinical Research
With 23 years of profound foundation in TCM R&D, we gather top-tier upstream and downstream resources to forge a domestic model of one-stop full-process services for TCM clinical research.
TCM Clinical Research
INTRODUCTION
Introduction
In response to the national call to vigorously develop traditional Chinese medicine (TCM), Boji Pharmaceutical fully integrated the team and resource advantages of full-process TCM R&D services, and established Xinglin TCM Technology (Guangzhou) Co., Ltd. (referred to as "Xinglin Technology") in 2022.
Xinglin Technology is a comprehensive CXO company fully focused on preclinical and clinical research of TCM. Leveraging Boji Pharmaceutical’s 23 years of expertise in TCM R&D services, it boasts rich practical experience and a solid talent pool across the entire new drug R&D process – including clinical trials, TCM pharmaceutical research, pharmacology and toxicology evaluation, registration and filing, clinical sample processing and production, and MAH (Marketing Authorization Holder) implementation. It is committed to building a one-stop comprehensive service leader that integrates TCM preclinical/clinical research, registration and filing, and achievement transformation.
Xinglin Technology is a comprehensive CXO company fully focused on preclinical and clinical research of TCM. Leveraging Boji Pharmaceutical’s 23 years of expertise in TCM R&D services, it boasts rich practical experience and a solid talent pool across the entire new drug R&D process – including clinical trials, TCM pharmaceutical research, pharmacology and toxicology evaluation, registration and filing, clinical sample processing and production, and MAH (Marketing Authorization Holder) implementation. It is committed to building a one-stop comprehensive service leader that integrates TCM preclinical/clinical research, registration and filing, and achievement transformation.
OUR SCALE
-
400+Clinical Research Services
-
20+The Indications Involved
-
1000+Cumulative Initiated Centers
-
40+Obtained Production Licenses
OUR ADVANTAGES
Extensive Institutional Cooperation
Our hospital network maintains extensive cooperation with TCM universities and their affiliated hospitals nationwide. For nationally accredited TCM hospitals, our cooperation rate hits 95%.
Top Expert Resources
Boasting a strong expert team, we engage in comprehensive cooperation with academician teams, national TCM review experts, FDA botanical drug experts, TCM clinical development experts, national TCM masters, and chairpersons of various professional committees, providing full demonstration and scientific control in overall design and strategy.
Comprehensive Upstream and Downstream Resources
We have accumulated abundant upstream resources including TCM universities, TCM hospitals and scientific research institutes, as well as a large number of downstream resources of TCM production and sales enterprises, achieving comprehensive connection through CRO services.
Abundant Project Experience
With 23 years of in-depth cultivation, Xinglin Technology's clinical research services cover the entire lifecycle of new TCM drugs, including Phase I-IV clinical research, registration and filing, overseas filing (for single-ingredient drugs), TCM protection research, cultivation of marketed products, and human experience data research.